ArticleEXCLI journal2026

Candesartan cilexetil as a repurposed therapeutic candidate for nasopharyngeal carcinoma: Integrated in vitro and in silico analyses.

Chawalit Ngernsombat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.